Loading...
Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis
BACKGROUND: Autologous haematopoietic stem cell transplantation (AHSCT) is an effective treatment for patients with multiple sclerosis (MS) who have highly active disease, despite the use of standard disease-modifying therapies (DMTs). However, the optimal time for offering AHSCT to patients with ‘a...
Na minha lista:
| Udgivet i: | Mult Scler |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8226372/ https://ncbi.nlm.nih.gov/pubmed/33565902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458520985238 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|